RxSight (RXST) CFO Mark Wilterding files Form 3 showing no share ownership

Rhea-AI Filing Summary

RxSight, Inc.’s Chief Financial Officer Mark Wilterding has filed an initial Form 3 reporting no share ownership. The filing states that no non-derivative or derivative securities of RxSight are beneficially owned as of the event date of January 11, 2026.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wilterding Mark

(Last) (First) (Middle)

100 COLUMBIA

(Street)

ALISO VIEJO CA 92656

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/11/2026

3. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bridget Balisy, as Attorney-in-Fact	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the RxSight (RXST) Form 3 filed by CFO Mark Wilterding show?

The Form 3 shows that CFO Mark Wilterding reports no beneficial ownership of RxSight securities. It is an initial statement of beneficial ownership, and both non-derivative and derivative securities tables indicate that no securities are beneficially owned as of January 11, 2026.

Who is the reporting person on the RxSight (RXST) Form 3 filing?

The reporting person is Mark Wilterding, Chief Financial Officer of RxSight, Inc. He is listed as an officer, not a director or 10% owner, and the filing confirms his role while also stating that he beneficially owns no RxSight securities as of the reported date.

Does RxSight CFO Mark Wilterding own any RxSight shares according to this Form 3?

According to the Form 3, Mark Wilterding does not beneficially own any RxSight securities. The explanation of responses explicitly states that no securities are beneficially owned, covering both non-derivative and derivative holdings as of January 11, 2026.

What is the event date referenced in the RxSight (RXST) Form 3?

The event date referenced in the Form 3 is January 11, 2026. This date is used as the point in time for determining and reporting Mark Wilterding’s beneficial ownership, which the filing states is zero RxSight securities on that date.

Is the RxSight Form 3 filed by more than one reporting person?

No, the Form 3 is filed by one reporting person, Mark Wilterding. The filing box for “Form filed by One Reporting Person” is checked, confirming that this initial beneficial ownership statement applies solely to the Chief Financial Officer.